Argos Therapeutics, Inc.
ARGS
ARGS was delisted on the 24th of April, 2018.
25 hedge funds and large institutions have $41M invested in Argos Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 4 closing their positions.
29% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 7
5% more capital invested
Capital invested by funds: $39.1M → $41M (+$1.9M)
4% less funds holding
Funds holding: 26 → 25 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$6.23M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$490K |
| 3 |
Ohio Public Employees Retirement System (OPERS)
Columbus,
Ohio
|
+$245K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$151K |
| 5 |
KeyBank National Association
Cleveland,
Ohio
|
+$76.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
-$613K |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$365K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$198K |
| 4 |
AGA
Altrinsic Global Advisors
Stamford,
Connecticut
|
-$152K |
| 5 |
SIP
Stoneridge Investment Partners
Radnor,
Pennsylvania
|
-$119K |
ARGS Hedge Fund Activity: Q1 2015 in Review
25 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Argos Therapeutics, Inc. (ARGS) for Q1 2015, worth a combined $41M — up 4.9% from $39.1M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ARGS and 3 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 9 added.
The largest buyer was Wasatch Advisors, adding an estimated $6.23M. The largest seller was Caisse de Depot et Placement du Quebec (CDPQ), cutting an estimated $613K.
- 25 institutional investors held Argos Therapeutics, Inc. (ARGS) as of Q1 2015, down from 26 in Q4 2014.
- Funds reported $41M of Argos Therapeutics, Inc. stock for Q1 2015, up 4.9% quarter-over-quarter.
- 3 funds opened new Argos Therapeutics, Inc. positions in Q1 2015 and 4 closed out, a net change of -1 holder.
- The largest Argos Therapeutics, Inc. buyer in Q1 2015 was Wasatch Advisors, an estimated $6.23M added.
- The largest Argos Therapeutics, Inc. seller in Q1 2015 was Caisse de Depot et Placement du Quebec (CDPQ), an estimated $613K sold.
Based on aggregated 13F filings for Q1 2015.